OBJECTIVEThis study examined illness-related change in intelligence quotient (IQ) in a cohort of youth with type 1 diabetes studied prospectively from disease onset in childhood to follow-up 12 years later in late adolescence/early adulthood.
RESEARCH DESIGN AND METHODSParticipants included type 1 diabetes patients (n = 95; mean age at follow-up 21.3 years) and healthy control participants (HCs; n = 67; mean age at follow-up 21.0 years) from a cohort followed prospectively. Measures included Wechsler Preschool and Primary Scale of Intelligence-Revised, Wechsler Intelligence Scale for ChildrenRevised, and Wechsler Abbreviated Scale of Intelligence and prospective collection of data on metabolic control history.
RESULTSYoung people with type 1 diabetes showed greater decline in verbal IQ (VIQ) and full-scale IQ (FSIQ), but not performance IQ (PIQ), than HCs. Within the diabetes group, a younger age at diabetes onset was associated with a decline in PIQ and FSIQ (P £ 0.001). A history of hypoglycemic seizures was associated with a decline in VIQ (P = 0.002). Long-term metabolic control was not associated with changes in IQ. Interaction terms were not significant, suggesting no moderating effect of one diabetes-related variable over another.
CONCLUSIONSThe presence of diabetes may negatively influence some aspects of IQ over time. Specific illness risk factors, such as an earlier age of disease onset and a history of hypoglycemic seizures, appear to put the young person at greater risk. Academic progress of children identified as at risk should be monitored and educational supports provided if necessary.A constant supply of glucose is critical for normal cerebral metabolism (1,2). Thus the brain is one of the major organ systems affected in type 1 diabetes, as glucose homeostasis is frequently disrupted, even in well-controlled diabetes (3). Developing brains have high cerebral energy needs associated with brain growth and neural pruning and may be more sensitive than adults to glucose fluctuations (3). It is important to document specific illness-related risk factors for brain changes in young people with type 1 diabetes. Better understanding of the impact of childhood-onset disease on the central nervous system (CNS) will facilitate evidence-based pediatric management A slide set summarizing this article is available online.